CompaniesNeurologix

Neurologix

defunct
About

Defunct Company

Areas of Focus

Categories

BankruptBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

3

As Collaborator

1

Total Enrollment

296

By Phase

NA: 1PHASE2: 1PHASE1: 1

By Status

TERMINATED: 2RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00643890
NCT01301573
Hover over trial bars to see details

Recent Trials

NCT04650425Collaborator
Causal Evidence for Task Regulation by Anterior Cingulate Cortex
NARecruiting
200 participants
Started: Apr 29, 2021 · Completed: Sep 30, 2024
NCT01301573Lead Sponsor
Long Term Follow-Up Study for rAAV-GAD Treated Subjects
N/ATerminated
40 participants
Started: Jan 31, 2011
NCT00643890Lead Sponsor
Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease
PHASE2Terminated
44 participants
Started: Aug 31, 2008
NCT00195143Lead Sponsor
Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease
PHASE1Completed
12 participants
Started: Aug 31, 2003 · Completed: Aug 31, 2005